Ginsenoside-Rb1-Mediated Anti-angiogenesis via Regulating PEDF and miR-33a through the Activation of PPAR-γ Pathway
暂无分享,去创建一个
Huixia Lu | Hoi-Hin Kwok | Po-Ying Poon | Hoi-Hin Kwok | Mei Dong | Huixia Lu | Xunian Zhou | Zhaoqiang Liu | Xiaorong Luan | Ricky Ngok-Shun Wong | Mei Dong | Xiaorong Luan | Xunian Zhou | Po-Ying Poon | Zhaoqiang Liu | Ricky Ngok-Shun Wong
[1] Daniel S. Ory,et al. miR-33 links SREBP-2 induction to repression of sterol transporters , 2010, Proceedings of the National Academy of Sciences.
[2] T. Imaizumi,et al. Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: a possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes. , 2008, Atherosclerosis.
[3] M. Norenberg,et al. Role of Matricellular Proteins in Disorders of the Central Nervous System , 2016, Neurochemical Research.
[4] K. Moore,et al. MiR-33 Contributes to the Regulation of Cholesterol Homeostasis , 2010, Science.
[5] W. Benedict,et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.
[6] Shiladitya Sengupta,et al. Modulating Angiogenesis: The Yin and the Yang in Ginseng , 2004, Circulation.
[7] S. Surapureddi,et al. Pigment epithelium-derived factor is an angiogenesis and lipid regulator that activates peroxisome proliferator-activated receptor alpha. , 2008, Advances in experimental medicine and biology.
[8] L. W. Cheung,et al. Ginsenoside Rb1 inhibits tube‐like structure formation of endothelial cells by regulating pigment epithelium‐derived factor through the oestrogen β receptor , 2007, British journal of pharmacology.
[9] Yong Cheng,et al. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action , 2005, Acta Pharmacologica Sinica.
[10] V. Koppaka,et al. anti* , 2002, Annals of Internal Medicine.
[11] Yuen-Kit Cheng,et al. Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides , 2007, Chinese medicine.
[12] E. Edelman,et al. miRNAs in atherosclerotic plaque initiation, progression, and rupture. , 2015, Trends in molecular medicine.
[13] C. Yuan,et al. Ginseng pharmacology: multiple constituents and multiple actions. , 1999, Biochemical pharmacology.
[14] L. Castellano,et al. Noncoding RNAs and the control of hormonal signaling via nuclear receptor regulation. , 2014, Journal of molecular endocrinology.
[15] R. Wong,et al. Ginsenoside-Rb1 Promotes Adipogenesis Through Regulation of PPARγ and MicroRNA-27b , 2012, Hormone and Metabolic Research.
[16] N. Bouck,et al. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] Longhou Fang,et al. Targeted cholesterol efflux , 2013, Cell cycle.
[18] A. Griffioen,et al. Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? , 2017, Angiogenesis.
[19] R. Wong,et al. Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[20] Katsuaki Sato,et al. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. , 1994, Biological & pharmaceutical bulletin.
[21] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[22] Huoming Zhang,et al. Role of G3BP1 in glucocorticoid receptor-mediated microRNA-15b and microRNA-23a biogenesis in endothelial cells , 2017, Cellular and Molecular Life Sciences.
[23] A. Tall,et al. ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation , 2010, Science.
[24] R. Wong,et al. Ginsenoside Rb₁ induces type I collagen expression through peroxisome proliferator-activated receptor-delta. , 2012, Biochemical pharmacology.
[25] S. Ko,et al. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells , 2004, Archives of pharmacal research.
[26] Jong-Hoon Kim,et al. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases , 2014, Journal of ginseng research.
[27] Chao Liu,et al. Control of Angiogenesis by AIBP-mediated Cholesterol Efflux , 2013, Nature.
[28] L. Chan,et al. MicroRNA-15b contributes to ginsenoside-Rg1-induced angiogenesis through increased expression of VEGFR-2. , 2013, Biochemical pharmacology.
[29] W. Filipowicz,et al. The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.
[30] S. Yamagishi,et al. Anti-atherothrombogenic properties of PEDF. , 2010, Current molecular medicine.
[31] K. Huber,et al. Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease , 2009, Expert opinion on therapeutic targets.
[32] J. Tombran-Tink,et al. PEDF in angiogenic eye diseases. , 2010, Current molecular medicine.
[33] S. Woods,et al. Antiobesity and Antihyperglycemic Effects of Ginsenoside Rb1 in Rats , 2010, Diabetes.
[34] P. Y.-K. Yue,et al. Ginsenoside-Rb 1 Promotes Adipogenesis Through , 2022 .
[35] I. Gérin,et al. Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation* , 2010, The Journal of Biological Chemistry.
[36] M. Wen. Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review , 2016, Front. Mol. Neurosci..
[37] Microvascular Plasticity: Angiogenesis in Health and Disease – Preface , 2016, Microcirculation.
[38] Huixia Lu,et al. PEDF improves atherosclerotic plaque stability by inhibiting macrophage inflammation response. , 2017, International journal of cardiology.
[39] Y. Tsao,et al. PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells. , 2007, Cardiovascular research.
[40] I. Chowers,et al. Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. , 2013, Cell metabolism.
[41] S. Yamagishi,et al. Pigment epithelium-derived factor (PEDF) and cardiometabolic disorders. , 2014, Current pharmaceutical design.
[42] Chunxiang Zhang. MicroRNAs in Vascular Biology and Vascular Disease , 2010, Journal of cardiovascular translational research.
[43] V. Notario,et al. The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential , 2013, Nature Reviews Cancer.
[44] N. Bouck. PEDF: anti-angiogenic guardian of ocular function. , 2002, Trends in molecular medicine.
[45] I. Cho. Effects of Panax ginseng in Neurodegenerative Diseases , 2012, Journal of ginseng research.